Literature DB >> 20877404

Chorioamnionitis: a multiorgan disease of the fetus?

M Gantert1, J V Been, A W D Gavilanes, Y Garnier, L J I Zimmermann, B W Kramer.   

Abstract

The bacterial infection of chorion and amnion is a common finding in premature delivery and is referred to as chorioamnionitis. As the mother rarely shows symptoms of a systemic inflammation, the course of chorioamnionitis is frequently asymptomatic and chronic. In contrast, the fetal inflammatory response syndrome represents a separate phenomenon, including umbilical inflammation and increased serum levels of proinflammatory cytokines in the fetus. Ascending maternal infections frequently lead to systemic fetal inflammatory reaction. Clinical studies have shown that antenatal exposure to inflammation puts the extremely immature neonates at a high risk for worsening pulmonary, neurological and other organ development. Interestingly, the presence of chorioamnionitis is associated with a lower rate of neonatal mortality in extremely immature newborns. In the following review, the pathogeneses of inflammation-associated perinatal morbidity are outlined. The concept of fetal multiorganic disease during intrauterine infection is introduced and discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20877404     DOI: 10.1038/jp.2010.96

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  55 in total

1.  Intra-amniotic administration of E coli lipopolysaccharides causes sustained inflammation of the fetal skin in sheep.

Authors:  Li Zhang; Masatoshi Saito; Alan Jobe; Suhas G Kallapur; John P Newnham; Thomas Cox; Boris Kramer; Huixia Yang; Matthew W Kemp
Journal:  Reprod Sci       Date:  2012-05-17       Impact factor: 3.060

Review 2.  Current concepts in maternal-fetal immunology: Recognition and response to microbial pathogens by decidual stromal cells.

Authors:  Anjali P Anders; Jennifer A Gaddy; Ryan S Doster; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2017-01-03       Impact factor: 3.886

3.  Functio laesa: the consequences of the fifth cardinal sign of inflammation in preterm infants.

Authors:  Laura Bennet
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

4.  Antenatal inflammation reduces expression of caveolin-1 and influences multiple signaling pathways in preterm fetal lungs.

Authors:  Steffen Kunzmann; Jennifer J P Collins; Yang Yang; Stefan Uhlig; Suhar G Kallapur; Christian P Speer; Alan H Jobe; Boris W Kramer
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

Review 5.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

Review 6.  Chorioamnionitis, IL-17A, and fetal origins of neurologic disease.

Authors:  Shelley M Lawrence; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-22       Impact factor: 3.886

7.  Histological Chorioamnionitis.

Authors:  A S Sagay
Journal:  J West Afr Coll Surg       Date:  2016 Jul-Sep

Review 8.  Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon; Yeon Mee Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

9.  Intraamniotic lipopolysaccharide exposure changes cell populations and structure of the ovine fetal thymus.

Authors:  Elke Kuypers; Tim G A M Wolfs; Jennifer J P Collins; Reint K Jellema; John P Newnham; Matthew W Kemp; Suhas G Kallapur; Alan H Jobe; Boris W Kramer
Journal:  Reprod Sci       Date:  2013-01-11       Impact factor: 3.060

10.  Antenatal glucocorticoids counteract LPS changes in TGF-β pathway and caveolin-1 in ovine fetal lung.

Authors:  Jennifer J P Collins; Steffen Kunzmann; Elke Kuypers; Matthew W Kemp; Christian P Speer; John P Newnham; Suhas G Kallapur; Alan H Jobe; Boris W Kramer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.